Single-step retrosynthesis is a central component of computer-aided synthesis planning, yet its intrinsically one-to-many nature is poorly captured by single-answer evaluation and benchmarking protocols. To address this, we introduce Top-K prompting as a robust training and inference paradigm to better capture diverse, plausible reaction predictions. We compile CREED-CCV-2+USPTO-XL, an ultra-large-scale dataset of ~45.6 million verified reactions to train the C3LM (Chemistry Constraint-Consistent Language Model). By integrating fine-tuning with ChemCensor-based and novelty-oriented rewards, our model achieves state-of-the-art performance on the OOD URSA-expert-2026 benchmark. Further analysis of reaction uniqueness shows that LLMs and conventional models explore complementary reaction spaces, motivating ensemble-based retrosynthesis systems. Overall, our results establish Top-K, plausibility-aware training as a practical new direction for robust future LLM-based synthesis planning.
Alex: Welcome to another episode of ResearchPod. Today we're looking at a paper about training language models to plan chemical reactions for drug discovery.
Sam: So this is about how computers help chemists figure out how to build complex molecules from scratch?
Alex: That's the core idea. To understand why it matters, think about how a chemist works. If you want to make a specific drug molecule, you can't just conjure it up. You have to figure out which simpler, cheaper chemicals you can start with, and which sequence of reactions will transform them into your target. That process of working backwards from the molecule you want to the ingredients you need is called retrosynthesis.
Sam: Like reverse-engineering a recipe.
Alex: Exactly. And the problem with traditional software is that it treats this like a lookup table—one target molecule, one correct answer. But real chemistry doesn't work that way. There are often dozens of valid routes to the same molecule, and a chemist might prefer one over another depending on cost, safety, or what equipment is available.
Sam: So the old tools were too rigid.
Alex: Right. And that's what this paper sets out to fix. The authors trained a specialized language model—think of it as a text-prediction system, similar in spirit to the kind that powers chatbots—but trained specifically on a large dataset of verified chemical reactions. The goal is to get it to generate not just one plausible route, but many diverse, chemically sensible ones.
Sam: How does a text-based model even handle chemistry? Molecules aren't words.
Alex: That's a fair question. The trick is a notation system called SMILES—short for Simplified Molecular Input Line Entry System. It encodes the structure of a molecule as a short string of characters. So instead of a diagram with atoms and bonds, you get something that looks a bit like a compact text code. The model reads and writes chemistry the same way it would handle language.
Sam: So the model is essentially writing chemistry as sentences, and then checking whether those sentences are grammatically correct—chemically speaking.
Alex: That's a good way to put it. And checking that "grammar" is where a tool the paper calls ChemCensor comes in. It's a scoring system that evaluates how plausible a proposed reaction actually is—measuring what proportion of the steps in a suggested pathway pass chemical validation, weighted by how confident the model is in each step. It's not just asking "does this look right?" It's asking "does this hold up under scrutiny?"
Sam: So instead of just pattern-matching text strings, the system is actually judging the underlying chemistry before deciding whether a pathway is worth keeping.
Alex: Precisely. And that's what allows it to explore multiple routes rather than committing to one. It can generate a range of candidates, score them, and surface the ones that are most chemically credible.
Sam: What are the limits of that approach?
Alex: A few worth noting. First, the training data is largely drawn from patent literature—reactions that have already been documented and filed. That means novel chemistry, things that haven't been patented yet, might fall outside what the model knows well.
Sam: So it's working from an existing map, not charting genuinely new territory.
Alex: That's a fair characterization. Second, the way they measure diversity in the model's outputs is by checking whether the text strings look different from one another. That's a reasonable starting point, but it doesn't tell you whether the underlying reaction mechanisms are actually distinct—two routes might look different on paper but follow the same chemical logic.
Sam: And the dataset itself—how was it generated?
Alex: It relies on a template-based engine, which means it builds reactions by applying known patterns. That's efficient, but it can introduce a bias toward familiar chemistry. The model may be less comfortable with reaction types that don't fit established templates.
Sam: Are there any safety concerns with a tool that can plan the synthesis of complex molecules?
Alex: The paper addresses this directly. Any tool capable of planning complex chemical synthesis could theoretically be misused. The authors were careful in how they benchmarked the system—focusing on medicinal chemistry targets and avoiding databases that include hazardous compounds. They also advocate for safety-aligned development practices, keeping the focus on beneficial clinical outcomes.
Sam: So the tool itself doesn't contain a roadmap to dangerous substances, but the broader point is that the field needs to stay alert to how these systems are used.
Alex: That's the position the paper takes, yes.
Sam: Stepping back—what does this actually change for a working chemist?
Alex: It shifts the model from a rigid guesser into something more like a flexible brainstorming partner. Instead of being handed one textbook answer, a chemist gets a range of plausible routes to evaluate. They still need to validate those routes in the lab—real yields, tricky solvents, practical constraints—but the cognitive work of generating options is substantially reduced.
Sam: So it's an advanced brainstorming tool, not an autonomous factory.
Alex: Exactly. And that's probably the right framing. The value isn't that it replaces chemical expertise—it's that it extends what a chemist can explore in a given amount of time. That brings our look at this research to a close. Thanks for listening to ResearchPod.